We have a patent portfolio covering hUC-MSC based technologies and other proprietary regenerative product candidates and technologies, as well as for elements of our GMP manufacturing processes.​ We will continue to protect and expand our extensive estate of patent rights and trade secrets. We believe this enables us to deliver commercial advantages and long-term protection for our product candidates based on our proprietary technologies.